Belite Bio [BLTE] vs Bio-Techne [TECH] Detailed Stock Comparison

Belite Bio, Inc.

NASDAQ
Loading...

Bio-Techne Corporation

NASDAQ
Loading...

TLDR: Quick Comparison Summary

Based on 21 vital metrics comparison: Belite Bio, Inc. wins in 4 metrics, Bio-Techne Corporation wins in 12 metrics, with 0 ties. Bio-Techne Corporation appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric Belite Bio, Inc. Bio-Techne Corporation Better
P/E Ratio (TTM) -69.65 117.16 Bio-Techne Corporation
Price-to-Book Ratio 8.23 4.55 Bio-Techne Corporation
Debt-to-Equity Ratio 0.06 20.07 Belite Bio, Inc.
PEG Ratio -0.59 -0.82 Belite Bio, Inc.
EV/EBITDA -69.65 28.87 Bio-Techne Corporation
Profit Margin (TTM) 0.00% 6.41% Bio-Techne Corporation
Operating Margin (TTM) 0.00% 14.51% Bio-Techne Corporation
EBITDA Margin (TTM) N/A 14.51% N/A
Return on Equity -16.94% 3.80% Bio-Techne Corporation
Return on Assets (TTM) -11.29% 6.09% Bio-Techne Corporation
Free Cash Flow (TTM) $-37.17M $256.55M Bio-Techne Corporation
Dividend Yield N/A 0.62% N/A
1-Year Return 122.26% 6.78% Belite Bio, Inc.
Price-to-Sales Ratio (TTM) N/A 7.35 N/A
Enterprise Value $5.85B $9.19B Bio-Techne Corporation
EV/Revenue Ratio N/A 7.56 N/A
Gross Profit Margin (TTM) N/A 62.72% N/A
Revenue per Share (TTM) $0 $8 Bio-Techne Corporation
Earnings per Share (Diluted) $-2.31 $0.49 Bio-Techne Corporation
Beta (Stock Volatility) -1.22 1.47 Belite Bio, Inc.
Short % of Float 5.38% 5.09% Bio-Techne Corporation

Belite Bio, Inc. vs Bio-Techne Corporation Stock Performance Analysis

Loading Price Chart...

BLTE
TECH

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Belite Bio, Inc.1.70%-3.42%-11.18%-18.26%-9.59%-13.84%
Bio-Techne Corporation2.17%5.74%-7.11%-10.77%-20.32%-14.75%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Belite Bio, Inc.122.26%740.70%264.27%309.84%855.47%855.47%
Bio-Techne Corporation6.78%-37.73%-51.28%86.91%161.27%281.12%

Performance & Financial Health Analysis: Belite Bio, Inc. vs Bio-Techne Corporation

MetricBLTETECH
Market Information
Market Cap i$6.44B$9.07B
Market Cap CategoryMid capMid cap
10 Day Avg. Volume i133,8602,151,790
90 Day Avg. Volume i158,8032,370,067
Last Close$137.23$50.85
52 Week Range$56.10 - $200.00$43.20 - $72.16
% from 52W High-31.39%-29.53%
All-Time High$200.00 (Feb 03, 2026)$135.96 (Sep 20, 2021)
% from All-Time High-31.39%-62.60%
Growth Metrics
Quarterly Revenue GrowthN/A-0.01%
Quarterly Earnings GrowthN/A0.14%
Financial Health
Profit Margin (TTM) i0.00%0.06%
Operating Margin (TTM) i0.00%0.15%
Return on Equity (TTM) i-0.17%0.04%
Debt to Equity (MRQ) i0.0620.07
Cash & Liquidity
Book Value per Share (MRQ)$19.59$12.62
Cash per Share (MRQ)$12.52$0.93
Operating Cash Flow (TTM) i$-36,988,000$251.25M
Levered Free Cash Flow (TTM) i$-9,765,250$274.30M
Dividends
Last 12-Month Dividend Yield iN/A0.62%
Last 12-Month Dividend i$0.00$0.40

Valuation & Enterprise Metrics Analysis: Belite Bio, Inc. vs Bio-Techne Corporation

MetricBLTE (Apr 26, 2026)TECH (Nov 10, 2025)
Price Ratios
P/E Ratio (TTM) i-69.65117.16
Forward P/E i205.4326.21
PEG Ratio i-0.59-0.82
Price to Sales (TTM) iN/A7.35
Price to Book (MRQ) i8.234.55
Market Capitalization
Market Capitalization i$6.44B$9.07B
Enterprise Value i$5.85B$9.19B
Enterprise Value Metrics
Enterprise to Revenue iN/A7.56
Enterprise to EBITDA i-69.6528.87
Risk & Other Metrics
Beta i-1.221.47
Book Value per Share (MRQ) i$19.59$12.62

Financial Statements Comparison: Belite Bio, Inc. vs Bio-Techne Corporation

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricBLTE (2025)TECH (2025)
Revenue/Sales i01.22B
Cost of Goods Sold iN/A429.36M
COGS % of Revenue i-35.2%
Gross Profit iN/A790.27M
Gross Margin i-64.8%
Research & Development i45.38M99.50M
Operating Income (EBIT) i-84.21M242.80M
Operating Margin i-19.9%
EBITDA i-77.15M357.57M
EBITDA Margin i-29.3%
Pre-Tax Income i-77.61M98.46M
Pre-Tax Income % of Revenue i-8.1%
Income Tax i025.06M
Income Tax % of Revenue i-2.1%
Net Income (Profit) i-77.61M73.40M
Profit Margin i-6.0%

Balance Sheet & Liquidity Metrics

MetricBLTE (2025)TECH (2025)
Cash & Equivalents i352.93M162.19M
Total Current Assets i494.27M608.30M
Total Current Assets % of Revenue i-49.9%
Total Current Liabilities i9.88M175.85M
Total Current Liabilities % of Revenue i-14.4%
Long-Term Debt i188,000429.96M
Long-Term Debt % of Revenue i-35.3%
Total Shareholders Equity i770.49M1.92B
Retained Earnings i-185.26M1.07B
Retained Earnings % of Revenue i-87.4%
Property, Plant & Equipment i1.02M73.40M

Cash Flow Statement Comparison

MetricBLTE (2025)TECH (2025)
Operating Cash Flow i-39.91M185.64M
Operating Cash Flow % of Revenue i-15.2%
Capital Expenditures i-178,000-31.01M
Free Cash Flow i-37.17M256.55M
FCF Margin i-21.0%
Debt Repayment iN/A-77.00M
Common Stock Repurchase iN/A-275.73M

Short Interest & Institutional Ownership Analysis

MetricBLTETECH
Shares Short i1.11M6.94M
Short Ratio i6.602.59
Short % of Float i5.38%5.09%
Shares Outstanding i39.34M154.97M
Float Shares i18.50M153.94M
% Held by Insiders i44.43%0.28%
% Held by Institutions i18.71%102.89%
% Held by Public i36.86%-3.17%

Dividend Analysis & Yield Comparison: Belite Bio, Inc. vs Bio-Techne Corporation

MetricBLTETECH
Last 12-Month Dividend i$0.00$0.40
Last 12-Month Dividend Yield iN/A0.62%
3-Year Avg Annual Dividend i$0.00$0.32
3-Year Avg Dividend Yield iN/A0.12%
3-Year Total Dividends i$0.00$0.96
Ex-Dividend DateN/AFeb 13, 2026